Clinical Trial Update: Artificial Intelligence in Lung Cancer Screening

View source ↗

Summary

A completed clinical trial evaluating the use of artificial intelligence to improve lung cancer screening, including individuals with asbestos exposure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asbestosis
• Lung Cancer
• Malignant Mesothelioma

Snippet

Sponsor: Scientific Institute San Raffaele | Conditions: Lung Cancer Screening, Asbestos | Status: COMPLETED